Literature DB >> 2427305

Dexamethasone stimulates the biochemical differentiation of fetal forebrain cells in reaggregating cultures.

G Almazan, P Honegger, P Du Pasquier, J M Matthieu.   

Abstract

The influence of dexamethasone on the development of neurons and oligodendrocytes was studied in serum-free, aggregating rat brain cell cultures. Synaptogenesis and myelination occur in this culture system. The concentration of myelin basic protein and the activity of 2',3'-cyclic nucleotide 3'-phosphodiesterase were used as oligodendroglia and myelin markers. Choline acetyltransferase and acetylcholinesterase served as neuronal markers, glutamine synthetase reflected astrocyte differentiation, while ornithine decarboxylase served as a general marker for cell growth and maturation. This study showed that dexamethasone stimulated the differentiation of cholinergic neurons and astrocytes. The effect of dexamethasone on oligodendroglial differentiation and myelination depended on the stage of development: during the early phase of myelination dexamethasone had a stimulatory effect, whereas at a later stage it showed a significant inhibition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427305     DOI: 10.1159/000112237

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  9 in total

1.  Differential regulation of oligodendrocyte markers by glucocorticoids: post-transcriptional regulation of both proteolipid protein and myelin basic protein and transcriptional regulation of glycerol phosphate dehydrogenase.

Authors:  S Kumar; R Cole; F Chiappelli; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  Administration of dexamethasone to neonatal rats induces hypomyelination and changes in the morphology of oligodendrocyte precursors.

Authors:  Jong-Wan Kim; Young J Kim; Young P Chang
Journal:  Comp Med       Date:  2013-02       Impact factor: 0.982

3.  Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats.

Authors:  Stefan A Mann; Beatrix Versmold; Romy Marx; Sabine Stahlhofen; Irmgard D Dietzel; Rolf Heumann; Richard Berger
Journal:  J Neuroinflammation       Date:  2008-09-22       Impact factor: 8.322

Review 4.  Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.

Authors:  Carla Marinelli; Thomas Bertalot; Morena Zusso; Stephen D Skaper; Pietro Giusti
Journal:  Front Cell Neurosci       Date:  2016-02-12       Impact factor: 5.505

5.  Preliminary Evidence of Increased Hippocampal Myelin Content in Veterans with Posttraumatic Stress Disorder.

Authors:  Linda L Chao; Duygu Tosun; Steven H Woodward; Daniela Kaufer; Thomas C Neylan
Journal:  Front Behav Neurosci       Date:  2015-12-02       Impact factor: 3.558

Review 6.  Hormonal Regulation of Oligodendrogenesis I: Effects across the Lifespan.

Authors:  Kimberly L P Long; Jocelyn M Breton; Matthew K Barraza; Olga S Perloff; Daniela Kaufer
Journal:  Biomolecules       Date:  2021-02-14

7.  Effects of Long-Term Endogenous Corticosteroid Exposure on Brain Volume and Glial Cells in the AdKO Mouse.

Authors:  Jorge Miguel Amaya; Ernst Suidgeest; Isabelle Sahut-Barnola; Typhanie Dumontet; Nathanaëlle Montanier; Guilhem Pagès; Cécile Keller; Louise van der Weerd; Alberto M Pereira; Antoine Martinez; Onno C Meijer
Journal:  Front Neurosci       Date:  2021-02-10       Impact factor: 4.677

Review 8.  Evidence for adverse effect of perinatal glucocorticoid use on the developing brain.

Authors:  Young Pyo Chang
Journal:  Korean J Pediatr       Date:  2014-03-31

9.  Stress and glucocorticoids promote oligodendrogenesis in the adult hippocampus.

Authors:  Sundari Chetty; Aaron R Friedman; Kereshmeh Taravosh-Lahn; Elizabeth D Kirby; Christian Mirescu; Fuzheng Guo; Danna Krupik; Andrea Nicholas; Anna Geraghty; Amrita Krishnamurthy; Meng-Ko Tsai; David Covarrubias; Alana Wong; Darlene Francis; Robert M Sapolsky; Theo D Palmer; David Pleasure; Daniela Kaufer
Journal:  Mol Psychiatry       Date:  2014-02-11       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.